Search by Drug Name or NDC

    NDC 68462-0470-54 Bumetanide 0.25 mg/mL Details

    Bumetanide 0.25 mg/mL

    Bumetanide is a INTRAMUSCULAR; INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by GLENMARK PHARMACEUTICALS INC., USA. The primary component is BUMETANIDE.

    Product Information

    NDC 68462-0470
    Product ID 68462-470_680563fe-5d3a-49bc-86a5-740bda2acebe
    Associated GPIs
    GCN Sequence Number 008220
    GCN Sequence Number Description bumetanide VIAL 0.25 MG/ML INJECTION
    HIC3 R1M
    HIC3 Description LOOP DIURETICS
    GCN 34810
    HICL Sequence Number 003664
    HICL Sequence Number Description BUMETANIDE
    Brand/Generic Generic
    Proprietary Name Bumetanide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Bumetanide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAMUSCULAR; INTRAVENOUS
    Active Ingredient Strength 0.25
    Active Ingredient Units mg/mL
    Substance Name BUMETANIDE
    Labeler Name GLENMARK PHARMACEUTICALS INC., USA
    Pharmaceutical Class Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA216434
    Listing Certified Through 2024-12-31

    Package

    NDC 68462-0470-54 (68462047054)

    NDC Package Code 68462-470-54
    Billing NDC 68462047054
    Package 10 VIAL, MULTI-DOSE in 1 CARTON (68462-470-54) / 10 mL in 1 VIAL, MULTI-DOSE (68462-470-40)
    Marketing Start Date 2023-01-01
    NDC Exclude Flag N
    Pricing Information N/A